Cargando…

COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency

Background The coronavirus disease 2019 (COVID-19) vaccinations have brought new hope to the world and have a significant psychosocial impact on communities as well as healthcare systems around the globe. This study aimed to assess the antibody titer level among healthcare workers after at least six...

Descripción completa

Detalles Bibliográficos
Autores principales: Ammar, Ali, Shah, Jehangir A, Khan, Waqar, Kumar, Rajesh, Shaikh, Abdul H, Ali, Farheen, Zehra, Mehwish, Sial, Jawaid A, Saghir, Tahir, Rehman, Zahid U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033517/
https://www.ncbi.nlm.nih.gov/pubmed/35481298
http://dx.doi.org/10.7759/cureus.23383
_version_ 1784692908924862464
author Ammar, Ali
Shah, Jehangir A
Khan, Waqar
Kumar, Rajesh
Shaikh, Abdul H
Ali, Farheen
Zehra, Mehwish
Sial, Jawaid A
Saghir, Tahir
Rehman, Zahid U
author_facet Ammar, Ali
Shah, Jehangir A
Khan, Waqar
Kumar, Rajesh
Shaikh, Abdul H
Ali, Farheen
Zehra, Mehwish
Sial, Jawaid A
Saghir, Tahir
Rehman, Zahid U
author_sort Ammar, Ali
collection PubMed
description Background The coronavirus disease 2019 (COVID-19) vaccinations have brought new hope to the world and have a significant psychosocial impact on communities as well as healthcare systems around the globe. This study aimed to assess the antibody titer level among healthcare workers after at least six weeks of the second dose of the COVID-19 vaccine. Methods Participants of the study were healthcare workers of a tertiary care cardiac center including doctors, nursing staff, paramedics, and office staff. All participants were fully vaccinated with recommended double dose of available vaccine at least six weeks before the study. A blood sample of five milliliters was collected from all the participants by a trained phlebotomist at a local laboratory, and COVID-19 antibodies titer level was assessed using Food and Drug Administration (FDA) approved kit with a standard range of 1.0. This qualitative assay detects IgG and IgM as total antibodies targeted against nucleocapsid antigen performed on a fully automated cobas® 6000 analyzer (F. Hoffmann-La Roche Ltd, Basel, Switzerland) using electrochemiluminescence technology. COVID-19 antibodies titer levels were categorized as ≤100, 101-250, and >250. Results A total of 151 healthcare workers were included, of which 70.2% (106) were male. The history of COVID-19 infection before vaccination was found in 41.1% (62). The mean duration since the last dose of the vaccine was 89.6±40.07 days. In total 71.5% (108) had antibodies titer level of >250, which were mostly found in participants of younger age and who had previous COVID-19 infection. However, antibodies titer level of >250 were observed in 84% (21/25) at 61 to 90 days of vaccination, which declined to 80% (20/25) after 91 to 120 days and to 57.1% (32/56) after >120 days of vaccination. Conclusions Good antibodies titer levels were observed in vaccinated healthcare workers, especially in those who were younger and had previous COVID-19 infection.
format Online
Article
Text
id pubmed-9033517
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90335172022-04-26 COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency Ammar, Ali Shah, Jehangir A Khan, Waqar Kumar, Rajesh Shaikh, Abdul H Ali, Farheen Zehra, Mehwish Sial, Jawaid A Saghir, Tahir Rehman, Zahid U Cureus Allergy/Immunology Background The coronavirus disease 2019 (COVID-19) vaccinations have brought new hope to the world and have a significant psychosocial impact on communities as well as healthcare systems around the globe. This study aimed to assess the antibody titer level among healthcare workers after at least six weeks of the second dose of the COVID-19 vaccine. Methods Participants of the study were healthcare workers of a tertiary care cardiac center including doctors, nursing staff, paramedics, and office staff. All participants were fully vaccinated with recommended double dose of available vaccine at least six weeks before the study. A blood sample of five milliliters was collected from all the participants by a trained phlebotomist at a local laboratory, and COVID-19 antibodies titer level was assessed using Food and Drug Administration (FDA) approved kit with a standard range of 1.0. This qualitative assay detects IgG and IgM as total antibodies targeted against nucleocapsid antigen performed on a fully automated cobas® 6000 analyzer (F. Hoffmann-La Roche Ltd, Basel, Switzerland) using electrochemiluminescence technology. COVID-19 antibodies titer levels were categorized as ≤100, 101-250, and >250. Results A total of 151 healthcare workers were included, of which 70.2% (106) were male. The history of COVID-19 infection before vaccination was found in 41.1% (62). The mean duration since the last dose of the vaccine was 89.6±40.07 days. In total 71.5% (108) had antibodies titer level of >250, which were mostly found in participants of younger age and who had previous COVID-19 infection. However, antibodies titer level of >250 were observed in 84% (21/25) at 61 to 90 days of vaccination, which declined to 80% (20/25) after 91 to 120 days and to 57.1% (32/56) after >120 days of vaccination. Conclusions Good antibodies titer levels were observed in vaccinated healthcare workers, especially in those who were younger and had previous COVID-19 infection. Cureus 2022-03-22 /pmc/articles/PMC9033517/ /pubmed/35481298 http://dx.doi.org/10.7759/cureus.23383 Text en Copyright © 2022, Ammar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Allergy/Immunology
Ammar, Ali
Shah, Jehangir A
Khan, Waqar
Kumar, Rajesh
Shaikh, Abdul H
Ali, Farheen
Zehra, Mehwish
Sial, Jawaid A
Saghir, Tahir
Rehman, Zahid U
COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency
title COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency
title_full COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency
title_fullStr COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency
title_full_unstemmed COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency
title_short COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency
title_sort covid-19 antibodies in vaccinated healthcare workers: the security currency
topic Allergy/Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033517/
https://www.ncbi.nlm.nih.gov/pubmed/35481298
http://dx.doi.org/10.7759/cureus.23383
work_keys_str_mv AT ammarali covid19antibodiesinvaccinatedhealthcareworkersthesecuritycurrency
AT shahjehangira covid19antibodiesinvaccinatedhealthcareworkersthesecuritycurrency
AT khanwaqar covid19antibodiesinvaccinatedhealthcareworkersthesecuritycurrency
AT kumarrajesh covid19antibodiesinvaccinatedhealthcareworkersthesecuritycurrency
AT shaikhabdulh covid19antibodiesinvaccinatedhealthcareworkersthesecuritycurrency
AT alifarheen covid19antibodiesinvaccinatedhealthcareworkersthesecuritycurrency
AT zehramehwish covid19antibodiesinvaccinatedhealthcareworkersthesecuritycurrency
AT sialjawaida covid19antibodiesinvaccinatedhealthcareworkersthesecuritycurrency
AT saghirtahir covid19antibodiesinvaccinatedhealthcareworkersthesecuritycurrency
AT rehmanzahidu covid19antibodiesinvaccinatedhealthcareworkersthesecuritycurrency